Vascular Closure Device Complications: The Case is Not Closed Yet

Journal of Invasive Cardiology

Volumn 16, Issue 5, 2004, Pages 251-

  Aggarwal, Kul ^a   Murtaza, Muhammad ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PYRIDINE DERIVATIVE; SEALANT;

ARTERIOTOMY; COMPRESSION THERAPY; DEVICE; HEART CATHETERIZATION; NOTE; PERCUTANEOUS CORONARY INTERVENTION; SAFETY; STAPLER; STENT; SUTURE; VASCULAR CLOSURE DEVICE COMPLICATION; VASCULAR DISEASE;

FEMORAL ARTERY; FIBRIN TISSUE ADHESIVE; HEART CATHETERIZATION; HEMOSTASIS, SURGICAL; HUMANS; PRESSURE; PUNCTURES; RISK FACTORS; SURGICAL EQUIPMENT; SUTURES;

EID: 2442464811     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. Popma JJ, Satler LF, Pichard AD, et al. Vascular complications after balloon and new device angioplasty. Circulation 1993;88:1569-1578.
2. Nasser TK, Mohler ER, Wilensky RL, Hathaway DR. Peripheral vascular complications following coronary interventional procedures. Clin Cardiol 1995;18:609-614.
3. Mandak JS, Blankenship JC, Gardner LH. Modifiable risk factors for vascular access site complications in the IMPACT II trial of angioplasty with versus without eptifibatide. J Am Coll Cardiol 1998;31:1518-1524.
4. Piper WD, Malenka DJ, Ryan TJ. Predicting vascular complications in percutaneous coronary interventions. Am Heart J 2003;145:1022-1029.
5. Resnic FS, Blake GS, Machado LO. Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb/IlIa inhibitors. Am J Cardiol 2001;88:493-496.
6. Chevalier B, Iancelin B, Koning R. Effect of closure device on complication rate in high-local-risk patients: Results of randomized multi-center trial. Cathet Cardiovasc Interven 2003;58:285-291.
7. Dangas G, Mehran R, Kokolis S. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arterial puncture closing devices. J Am Coll Cardiol 2001;38:638-641.
8. Applegate RJ, Grabarczyk MA, Little WC. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa inhibitors during percutaneous revascularization. J Am Coll Cardiol 2002;40:78-83.
9. Exaire JE, Dauerman HL, Topol EJ. Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices. Am Heart J 2004;147:31-34.
10. Korney M, Riedmuller E, Nikfardjam M, et al. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: Systemic review and meta-analysis. J Am Med Assoc 2004;291:350-357.